Australia markets closed

AFT Pharmaceuticals Limited (AFP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
3.35000.0000 (0.00%)
At close: 01:54PM AEDT

AFT Pharmaceuticals Limited

129 Hurstmere Road
Level 1 Takapuna
Auckland 0622
New Zealand
64 9 488 0232
https://www.aftpharm.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees97

Key executives

NameTitlePayExercisedYear born
Dr. Hartley Atkinson Ph.D.Co-Founder, CEO, MD & Exec. Director545.18kN/AN/A
Ms. Marree AtkinsonCo-Founder, Chief of Staff & Exec. Director95.6kN/AN/A
Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZCFO & Company Sec.N/AN/AN/A
Mr. Murray KeithGroup Marketing Mang.N/AN/AN/A
Ms. Ioana StanescuHead of Drug Devel.N/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, eyecare, first aid, pain management, gastrointestinal, dermatology, and medicated vitamins. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Corporate governance

AFT Pharmaceuticals Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.